The Gabelli Healthcare & Wellness Trust (GRX) Fair Value & Analysis
Financial Services · US · Market cap $134M
The Gabelli Healthcare & Wellness Trust
GRX · US
Fair value as of: Jun 26, 2026
From 22 valuation models · updated 3 days ago
Share price +6.5% over the past month.
Price vs Fair Value (12 months)
12‑month range $8.22 – $9.46 · fair‑value band $1.98 – $3.30 · the $9.27 price screens above the $2.64 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
The Gabelli Healthcare & Wellness Trust (GRX) currently trades at $9.27, while our model-based Fair Value estimate is $2.64 — implying the stock looks roughly 71.5% overvalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Net debt stands at $70.7M. The stock trades on a trailing P/E of 59.3. Fundamentals as of Jun 26, 2026
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
The Gabelli Healthcare & Wellness Trust reported revenue of $15.3M in FY2025 versus $43.5M in FY2021, a compound −23.0%/yr. Reported net income was $2.3M in FY2025, compounding −51.9%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $4.20 | $6.41 | +53% |
| The Schiehallion Fund Limited MNTN | $0.0214 | $0.0400 | +87% |
| BlackRock, Inc BLK | 17,417 MXN | 10,294 MXN | -41% |
| BH Macro Limited BHMU | $4.42 | $8.84 | +100% |
| Blackstone Inc BX | $118.55 | $61.04 | -49% |
| Investor AB IVSBF | $39.99 | $79.98 | +100% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is The Gabelli Healthcare & Wellness Trust (GRX) undervalued?
What is the fair value of GRX?
What is the quality score of GRX?
What is the net profit margin of GRX?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.